Ctt Pharmaceutical Holdings annual net income
2010
2011
2012
2013
2014
2024
2025
Ctt Pharmaceutical Holdings Net Income Growth & History (CTTH)
Ctt Pharmaceutical Holdings's net income was −$155,907 for fiscal 2025.
View full Ctt Pharmaceutical Holdings company overviewCtt Pharmaceutical Holdings annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$155,907 | $94,322 | — |
| 2024 | 2024-12-31 | −$250,229 | — | — |
| 2014 | 2014-12-31 | −$672,162 | −$653,251 | — |
| 2013 | 2013-12-31 | −$18,911 | $984,277 | — |
| 2012 | 2012-12-31 | −$1.0M | −$4.7M | — |
| 2011 | 2011-12-31 | $3.7M | $4.8M | — |
| 2010 | 2010-12-31 | −$1.1M | — | — |
Ctt Pharmaceutical Holdings quarterly net income
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$15,234 | $45,495 | — |
| Q1 2026 | 2026-03-31 | −$84,674 | −$55,130 | — |
| Q4 2025 | 2025-12-31 | −$50,255 | — | — |
| Q3 2025 | 2025-09-30 | −$15,379 | — | — |
| Q2 2025 | 2025-06-30 | −$60,729 | — | — |
| Q1 2025 | 2025-03-31 | −$29,544 | — | — |
| Q3 2015 | 2015-09-30 | −$341,930 | −$298,734 | — |
| Q2 2015 | 2015-06-30 | −$362,657 | −$361,737 | — |
| Q1 2015 | 2015-03-31 | −$337,052 | −$335,379 | — |
| Q4 2014 | 2014-12-31 | −$626,373 | −$720,093 | — |
| Q3 2014 | 2014-09-30 | −$43,196 | −$34,723 | — |
| Q2 2014 | 2014-06-30 | −$920 | $62,789 | — |
| Q1 2014 | 2014-03-31 | −$1,673 | $38,776 | — |
| Q4 2013 | 2013-12-31 | $93,720 | $369,953 | — |
| Q3 2013 | 2013-09-30 | −$8,473 | $100,520 | — |
| Q2 2013 | 2013-06-30 | −$63,709 | −$28,123 | — |
| Q1 2013 | 2013-03-31 | −$40,449 | $541,927 | — |
| Q4 2012 | 2012-12-31 | −$276,233 | $153,626 | — |
| Q3 2012 | 2012-09-30 | −$108,993 | $333,129 | — |
| Q2 2012 | 2012-06-30 | −$35,586 | $1.0M | — |
| Q1 2012 | 2012-03-31 | −$582,376 | −$6.3M | — |
| Q4 2011 | 2011-12-31 | −$429,859 | — | — |
| Q3 2011 | 2011-09-30 | −$442,122 | $145 | — |
| Q2 2011 | 2011-06-30 | −$1.1M | −$1.1M | — |
| Q1 2011 | 2011-03-31 | $5.7M | — | — |
| Q3 2010 | 2010-09-30 | −$442,267 | — | — |
| Q2 2010 | 2010-06-30 | −$1,383 | — | — |
Ctt Pharmaceutical Holdings net income trends
Between the periods ended 2010-12-31 and 2025-12-31, Ctt Pharmaceutical Holdings's net income increased from −$1.1M to −$155,907, a change of $941,812. The latest reported quarter, Q2 2026, shows −$15,234.
About the metric
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
Calculation and source
SEC-reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ctt Pharmaceutical Holdings source filings ↗